Does biological agent treatment have an impact on serum uric acid levels in patients with psoriasis?

References

• Campanati A, Marani A, Martina E, et al. Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches. Biomedicines. 2021;9(11):1511. doi: 10.3390/biomedicines9111511.
   PubMed Web of Science ®Google Scholar
• Damiani G, Bragazzi NL, Karimkhani Aksut C, et al. The global, regional, and national burden of psoriasis: results and insights from the Global Burden of Disease 2019 study. Front Med (Lausanne). 2021;8:743180. doi: 10.3389/fmed.2021.743180.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Damiani G, Genovese G, et al. A dermatologic perspective on autoinflammatory diseases. Clin Exp Rheumatol. 2018;36(1):32–38.
   PubMed Web of Science ®Google Scholar
• Ogawa E, Sato Y, Minagawa A, et al. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018;45(3):264–272. doi: 10.1111/1346-8138.14139.
   PubMed Web of Science ®Google Scholar
• Gisondi P, Piaserico S, Naldi L, et al. Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: a Northern Italy experience. J Allergy Clin Immunol. 2021;147(2):558–560.e1. doi: 10.1016/j.jaci.2020.10.032.
   PubMed Web of Science ®Google Scholar
• Motolese A, Ceccarelli M, Macca L, et al. Novel therapeutic approaches to psoriasis and risk of infectious disease. Biomedicines. 2022;10(2):228. doi: 10.3390/biomedicines10020228.
   PubMed Web of Science ®Google Scholar
• Tripolino C, Ciaffi J, Ruscitti P, et al. Hyperuricemia in psoriatic arthritis: epidemiology, pathophysiology, and clinical implications. Front Med (Lausanne). 2021;8:737573. doi: 10.3389/fmed.2021.737573.
   PubMed Web of Science ®Google Scholar
• El Farargy S, Ghanayem N, Yehia H. Association between serum uric acid concentration and clinical features of psoriasis. Menoufia Med J. 2021;34(4):1255–1258.
   Google Scholar
• Gui XY, Jin HZ, Wang ZJ, et al. Serum uric acid levels and hyperuricemia in patients with psoriasis: a hospital-based cross-sectional study. An Bras Dermatol. 2018;93(5):761–763. doi: 10.1590/abd1806-4841.20187547.
   PubMed Web of Science ®Google Scholar
• Marques E, Paluch Z, Boháč P, et al. Epidemiology of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents. J Dermatolog Treat. 2022;33(3):1435–1448. doi: 10.1080/09546634.2020.1826393.
   PubMed Web of Science ®Google Scholar
• Damiani G, Cazzaniga S, Conic RR, et al. Pruritus characteristics in a large italian cohort of psoriatic patients. J Eur Acad Dermatol Venereol. 2019;33(7):1316–1324. doi: 10.1111/jdv.15539.
   PubMed Web of Science ®Google Scholar
• Świerczyńska K, Białynicki-Birula R, Szepietowski JC. Chronic intractable pruritus in chronic kidney disease patients: prevalence, impact, and management challenges-a narrative review. Ther Clin Risk Manag. 2021;17:1267–1282. doi: 10.2147/TCRM.S310550.
   PubMed Web of Science ®Google Scholar
• Li X, Miao X, Wang H, et al. Association of serum uric acid levels in psoriasis: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(19):e3676. doi: 10.1097/MD.0000000000003676.
   PubMed Web of Science ®Google Scholar
• Daugaard C, Iversen L, Hjuler KF. Comorbidity in adult psoriasis: considerations for the clinician. Psoriasis (Auckl). 2022;12:139–150. doi: 10.2147/PTT.S328572.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Cai L, Zhang S, et al. Effects of secukinumab and adalimumab on serum uric acid level in patients with plaque psoriasis. Chin Med J (Engl). 2022;135(12):1438–1443. doi: 10.1097/CM9.0000000000002130.
   PubMed Web of Science ®Google Scholar
• Llamas-Velasco M, de la Cueva P, Notario J, et al. Moderate psoriasis: a proposed definition. Actas Dermosifiliogr. 2017;108(10):911–917. doi: 10.1016/j.adengl.2017.10.003.
   PubMed Web of Science ®Google Scholar
• Weir CB, Jan A. BMI Classification percentile and cut off points. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jun 5]. Available from: https://pubmed.ncbi.nlm.nih.gov/31082114/
   Google Scholar
• Sayami A, Gupta A, Gautam N. Association between serum uric acid level and psoriasis: a case control study. Nepal J Dermatol Venereol Leprol. 2021;19(1):50–54. doi: 10.3126/njdvl.v19i1.35958.
   Google Scholar
• Asrar Nazki FI, Nazir S, Ahmad Wani S, et al. A study on HbA1C and serum uric acid levels inpatients with psoriasis in Kashmiri population—a pilot study. Eur J Mol Clin Med. 2022;9(1):1040–1050.
   Google Scholar
• Gisondi P. Hyperuricemia in patients with chronic plaque psoriasis. Drug Dev Res. 2014;75(suppl 1):S70–S72.
   PubMedGoogle Scholar
• Lai TL, Yim CW, Wong PY, et al. Hyperuricemia in Asian psoriatic arthritis patients. Int J Rheum Dis. 2018;21(4):843–849. doi: 10.1111/1756-185X.13265.
   PubMed Web of Science ®Google Scholar
• Tsuruta N, Imafuku S, Narisawa Y. Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients. J Dermatol. 2017;44(12):1349–1352. doi: 10.1111/1346-8138.13968.
   PubMed Web of Science ®Google Scholar
• Mokhtarpour Neilagh A, Sadeghilar M, Aghazadeh Barenji M, et al. The correlation between psoriasis and uric acid serum level. Iranian J Dermatol. 2021;24(1):70–72.
   Google Scholar
• Gerkowicz A, Pietrzak A, Szepietowski JC, et al. Biochemical markers of psoriasis as a metabolic disease. Folia Histochem Cytobiol. 2012;50(2):155–170. doi: 10.5603/fhc.2012.0025.
   PubMed Web of Science ®Google Scholar
• Sun L, Guo X, Qin Y, et al. Serum intestinal metabolites are raised in patients with psoriasis and metabolic syndrome. Clin Cosmet Investig Dermatol. 2022;15:879–886. doi: 10.2147/CCID.S351984.
   PubMed Web of Science ®Google Scholar
• Chetana S, Manjunath SM, Manjula S, et al. Significance of serum uric acid levels in non-arthritic psoriasis with special reference to metabolic syndrome. Manipal J Med Sci. 2016;1(1):9–13.
   Google Scholar
• Elnabawi YA, Dey AK, Belur AD, et al. Serum uric acid levels are associated with non-calcified coronary plaque independent of traditional cardiovascular risk factors in patients with psoriasis. Circulation. 2018;137(suppl_1):AP049. doi: 10.1161/circ.137.suppl_1.p049.
   Google Scholar
• Goldman M. Uric acid in the etiology of psoriasis. Am J Dermatopathol. 1981;3(4):397–404. doi: 10.1097/00000372-198100340-00014.
   PubMed Web of Science ®Google Scholar
• Wei L, Mackenzie IS, Chen Y, et al. Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol. 2011;71(4):600–607. doi: 10.1111/j.1365-2125.2010.03887.x.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu L, Sun X, et al. Updated evidence of the association between elevated serum uric acid level and psoriasis. Front Med (Lausanne). 2021;8:645550. doi: 10.3389/fmed.2021.645550.
   PubMed Web of Science ®Google Scholar
• Hagino T, Saeki H, Fujimoto E, et al. Effects of biologic therapy on laboratory indicators of cardiometabolic diseases in patients with psoriasis. J Clin Med. 2023;12(5):1934. doi: 10.3390/jcm12051934.
   PubMed Web of Science ®Google Scholar
• Gerdes S, Pinter A, Papavassilis C, et al. Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients. J Eur Acad Dermatol Venereol. 2020;34(3):533–541. doi: 10.1111/jdv.16004.
   PubMed Web of Science ®Google Scholar